# Glenmark Pharmaceuticals Limited, Colvale, India – FDA Inspections

Source: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e

> Inspection records and compliance data for Glenmark Pharmaceuticals Limited in Colvale. 8 FDA inspections on record (1 OAI), 3 Form 483s, last inspected May 20, 2022.

---

## Details

- Name: Glenmark Pharmaceuticals Limited
- FEI Number: 3004672766
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Plot No S - 7, Colvale Industrial Estate
- City: Colvale
- Country Name: India
- Address: Plot No S - 7, Colvale Industrial Estate, Colvale, India
- Country: India

## Related Documents

- [483 - Glenmark Pharmaceuticals Limited - 2026-06-22](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/e98bef36-5600-4902-bbe5-6b857ceb88c1) — source: FDA, date: June 22, 2026
- [483 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/057fe8cd-6838-4327-af2d-357c2360ff67) — source: FDA, date: May 20, 2022
- [FDA Inspection 1170118 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/3db03adb-b93f-4e9a-8ec6-4f05144e5a4f) — classification: Official Action Indicated (OAI), source: FDA, date: May 20, 2022
- [483 - Glenmark Pharmaceuticals Limited - 2019-09-27](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/1b6b5a08-12ee-4621-95d3-64968e415cc1) — source: FDA, date: September 27, 2019
- [FDA Inspection 1103081 - Glenmark Pharmaceuticals Limited - 2019-09-27](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/2ecc5ee7-1d47-4269-84ae-e280ac4fbe41) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2019
- [483 - Glenmark Pharmaceuticals Limited - 2019-03-15](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/61572250-35a3-4c58-8beb-ef4ed0be77a2) — source: FDA, date: March 15, 2019
- [FDA Inspection 1082656 - Glenmark Pharmaceuticals Limited - 2019-03-15](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/76994ec3-3b82-446f-9cf1-7c06892b1e58) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2019
- [FDA Inspection 1011069 - Glenmark Pharmaceuticals Limited - 2017-03-31](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/a5c21800-ad37-4711-9700-04664fe379a5) — source: FDA, date: March 31, 2017
- FDA Inspection 885332 - Glenmark Pharmaceuticals Limited - 2014-05-30 — classification: No Action Indicated (NAI), source: FDA, date: May 30, 2014
- [FDA Inspection 849889 - Glenmark Pharmaceuticals Limited - 2013-07-19](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/d3bf1a09-8a2e-4b48-a074-e7143a83a5d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2013
- [FDA Inspection 752519 - Glenmark Pharmaceuticals Limited - 2011-10-12](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/ffeb2946-9761-4490-b5c7-658b5d38daaa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 12, 2011
- FDA Inspection 628368 - Glenmark Pharmaceuticals Limited - 2009-11-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2009

## Related Companies

- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/b7da9cbd-d5e3-417f-a485-f9e38852b256)
- [Macleods Pharmaceuticals Limited](https://www.keypedia.com/companies/macleods-pharmaceuticals-limited/f7fe72e6-90d2-4daf-83eb-27fb2d948c3d)
- [V-Ensure Pharma Technologies Pvt. Limited](https://www.keypedia.com/companies/v-ensure-pharma-technologies-pvt-limited/01233430-1062-49f9-ad93-adf95ab293e8)
- [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/62f2df1c-2c1e-4f8b-b4f7-40cf329f9298)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [Oxalis Labs](https://www.keypedia.com/companies/oxalis-labs/bc19741c-c2c0-43bc-80ad-91eda4acf921)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/d1295106-bf79-46f5-bf51-08338508f98e)
- [Novugen Pharma Sdn Bhd](https://www.keypedia.com/companies/novugen-pharma-sdn-bhd/fc9e6513-920b-4d9b-a395-3599ca7f16e7)
- [Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)](https://www.keypedia.com/companies/hybio-pharmaceutical-co-ltd-pingshan-factory/a9645470-bf0e-4ade-9133-9705219e306f)
- [Wanbang Biopharmaceuticals](https://www.keypedia.com/companies/wanbang-biopharmaceuticals/06ce9dd3-f258-4095-ab7d-df66357273c3)

## Related Officers

- [Sandra A. Hughes](https://www.keypedia.com/people/sandra-a-hughes/ee1b9542-fe28-4618-a666-67a1ff736481)
- [Michele L. Glendenning](https://www.keypedia.com/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)
- [Jose M. Cayuela](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
